136 related articles for article (PubMed ID: 19630517)
1. Was cDNA sequences modulate transgene expression of was promoter-driven lentiviral vectors.
Toscano MG; Benabdellah K; Muñoz P; Frecha C; Cobo M; Martín F
Hum Gene Ther; 2009 Nov; 20(11):1279-90. PubMed ID: 19630517
[TBL] [Abstract][Full Text] [Related]
2. Improved lentiviral vectors for Wiskott-Aldrich syndrome gene therapy mimic endogenous expression profiles throughout haematopoiesis.
Frecha C; Toscano MG; Costa C; Saez-Lara MJ; Cosset FL; Verhoeyen E; Martin F
Gene Ther; 2008 Jun; 15(12):930-41. PubMed ID: 18323794
[TBL] [Abstract][Full Text] [Related]
3. Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich syndrome gene.
Leuci V; Gammaitoni L; Capellero S; Sangiolo D; Mesuraca M; Bond HM; Migliardi G; Cammarata C; Aglietta M; Morrone G; Piacibello W
Stem Cells; 2009 Nov; 27(11):2815-23. PubMed ID: 19785032
[TBL] [Abstract][Full Text] [Related]
4. Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences.
Martín F; Toscano MG; Blundell M; Frecha C; Srivastava GK; Santamaría M; Thrasher AJ; Molina IJ
Gene Ther; 2005 Apr; 12(8):715-23. PubMed ID: 15750617
[TBL] [Abstract][Full Text] [Related]
5. Hematopoietic-specific lentiviral vectors circumvent cellular toxicity due to ectopic expression of Wiskott-Aldrich syndrome protein.
Toscano MG; Frecha C; Benabdellah K; Cobo M; Blundell M; Thrasher AJ; García-Olivares E; Molina IJ; Martin F
Hum Gene Ther; 2008 Feb; 19(2):179-97. PubMed ID: 18240968
[TBL] [Abstract][Full Text] [Related]
6. UMG Lenti: novel lentiviral vectors for efficient transgene- and reporter gene expression in human early hematopoietic progenitors.
Chiarella E; Carrà G; Scicchitano S; Codispoti B; Mega T; Lupia M; Pelaggi D; Marafioti MG; Aloisio A; Giordano M; Nappo G; Spoleti CB; Grillone T; Giovannone ED; Spina R; Bernaudo F; Moore MA; Bond HM; Mesuraca M; Morrone G
PLoS One; 2014; 9(12):e114795. PubMed ID: 25502183
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation.
Dupré L; Marangoni F; Scaramuzza S; Trifari S; Hernández RJ; Aiuti A; Naldini L; Roncarolo MG
Hum Gene Ther; 2006 Mar; 17(3):303-13. PubMed ID: 16544979
[TBL] [Abstract][Full Text] [Related]
8. Functional promoter testing using a modified lentiviral transfer vector.
Geller SF; Ge PS; Visel M; Greenberg KP; Flannery JG
Mol Vis; 2007 May; 13():730-9. PubMed ID: 17563724
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus vector driven by polybiquitin C promoter without woodchuck posttranscriptional regulatory element and central polypurine tract generates low level and short-lived reporter gene expression.
Ngai SC; Rosli R; Nordin N; Veerakumarasivam A; Abdullah S
Gene; 2012 May; 498(2):231-6. PubMed ID: 22366305
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients.
Charrier S; Dupré L; Scaramuzza S; Jeanson-Leh L; Blundell MP; Danos O; Cattaneo F; Aiuti A; Eckenberg R; Thrasher AJ; Roncarolo MG; Galy A
Gene Ther; 2007 Mar; 14(5):415-28. PubMed ID: 17051251
[TBL] [Abstract][Full Text] [Related]
11. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
[TBL] [Abstract][Full Text] [Related]
12. Expression and recombination of the EGFP and EYFP genes in lentiviral vectors carrying two heterologous promoters.
Dijon M; Torne-Celer C; Moreau T; Tonnelle C; Chabannon C
Cytotherapy; 2005; 7(5):417-26. PubMed ID: 16236631
[TBL] [Abstract][Full Text] [Related]
13. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
14. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
15. Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression.
Lizée G; Aerts JL; Gonzales MI; Chinnasamy N; Morgan RA; Topalian SL
Hum Gene Ther; 2003 Apr; 14(6):497-507. PubMed ID: 12718761
[TBL] [Abstract][Full Text] [Related]
16. Development of novel efficient SIN vectors with improved safety features for Wiskott-Aldrich syndrome stem cell based gene therapy.
Avedillo Díez I; Zychlinski D; Coci EG; Galla M; Modlich U; Dewey RA; Schwarzer A; Maetzig T; Mpofu N; Jaeckel E; Boztug K; Baum C; Klein C; Schambach A
Mol Pharm; 2011 Oct; 8(5):1525-37. PubMed ID: 21851067
[TBL] [Abstract][Full Text] [Related]
17. Repopulation of B-lymphocytes with restricted gene expression using haematopoietic stem cells engineered with lentiviral vectors.
Taher TE; Tulone C; Fatah R; D'Acquisto F; Gould DJ; Mageed RA
Gene Ther; 2008 Jul; 15(13):998-1006. PubMed ID: 18356817
[TBL] [Abstract][Full Text] [Related]
18. Off-on polyadenylation strategy as a supplemental mechanism for silencing toxic transgene expression during lentiviral vector production.
Bagnis C; Zwojsczyki G; Chiaroni J; Bailly P
Biotechniques; 2014 Jun; 56(6):311-2, 314-8. PubMed ID: 24924391
[TBL] [Abstract][Full Text] [Related]
19. Tightly regulated and homogeneous transgene expression in human adipose-derived mesenchymal stem cells by lentivirus with tet-off system.
Moriyama H; Moriyama M; Sawaragi K; Okura H; Ichinose A; Matsuyama A; Hayakawa T
PLoS One; 2013; 8(6):e66274. PubMed ID: 23776652
[TBL] [Abstract][Full Text] [Related]
20. Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors.
Muñoz P; Toscano MG; Real PJ; Benabdellah K; Cobo M; Bueno C; Ramos-Mejía V; Menendez P; Anderson P; Martín F
PLoS One; 2012; 7(6):e39091. PubMed ID: 22720040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
